Chartwell Investment Partners’s Alpine Immune Sciences Inc ALPN Stock Holding History

Chartwell Investment Partners’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-21,881	Closed	-$867K	–	444
2024 Q1	$867K	Buy	+21,881	New	+$646K	0.03%	377

Chartwell Investment Partners's ALPN Position: Q2 2024 in Review

Chartwell Investment Partners sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 21,881 shares — an estimated $867K sold.

Chartwell Investment Partners first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $867K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Chartwell Investment Partners reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Chartwell Investment Partners sold 21,881 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $867K.
Chartwell Investment Partners first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
Chartwell Investment Partners's Alpine Immune Sciences Inc position peaked at $867K in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Chartwell Investment Partners's 13F filing for Q2 2024, filed 8 Aug 2024.